The anti-tumor effect of Newcastle disease virus HN protein is influenced by differential subcellular targeting

Cancer Immunology, Immunotherapy

Volumn 59, Issue 7, 2010, Pages 989-999

  Sui, Hong ^a   Bai, Yuxian ^a   Wang, Kaibing ^a   Li, Xi ^b   Song, Chun ^c   Fu, Fang ^b   Zhang, Yongxin ^b   Li, Lejing ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Harbin Veterinary Research Institute   (China)

^c BEIJING HOSPITAL   (China)

Author keywords

Anti tumor effect; Cellular localization; CTL activity; Hemagglutinin neuraminidase (HN) protein; Non small cell lung cancer (NSCLC)

Indexed keywords

DNA VACCINE; HN PROTEIN; ONCOLYTIC VIRUS; CANCER VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER IMMUNOTHERAPY; CELL VIABILITY; CONTROLLED STUDY; CYTOPLASM; CYTOTOXIC T LYMPHOCYTE; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; LUNG NON SMALL CELL CANCER; LYMPHOCYTE PROLIFERATION; MOUSE; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOLYTIC VIROTHERAPY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN SECRETION; TARGET CELL; ANIMAL; APOPTOSIS; BAGG ALBINO MOUSE; CD8+ T LYMPHOCYTE; CELL MEMBRANE; CELL SURVIVAL; CYTOLOGY; CYTOTOXICITY; DRUG SCREENING; GENETICS; IMMUNOLOGY; LUNG TUMOR; NUDE MOUSE; PATHOLOGY; SECRETION; TRANSMISSION ELECTRON MICROSCOPY; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; CANCER VACCINES; CARCINOMA, NON-SMALL-CELL LUNG; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CELL MEMBRANE; CELL SURVIVAL; CYTOPLASM; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; HN PROTEIN; HUMANS; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROSCOPY, ELECTRON, TRANSMISSION; NEWCASTLE DISEASE VIRUS; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; VACCINES, DNA; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77953038121     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-010-0821-5     Document Type: Article

References (30)

1. DM Parkin F Bray J Ferlay P Pisani 2005 Global cancer statistics, 2002 CA Cancer J Clin 55 74 108 10.3322/canjclin.55.2.74 15761078
2. C Heise T Hermiston L Johnson, et al. 2000 An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy Nat Med 6 1134 1139 10.1038/80474 1:CAS:528:DC%2BD3cXntlKntbo%3D 11017145
3. FR Khuri J Nemunaitis I Ganly, et al. 2000 A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer Nat Med 6 879 885 10.1038/78638 1:CAS:528:DC%2BD3cXlsFKhtr0%3D 10932224 (Pubitemid 30644745)
4. K Nakano T Todo K Chijiiwa M Tanaka 2001 Therapeutic efficacy of G207, a conditionally replicating herpes simplex virus type 1 mutant, for gallbladder carcinoma in immunocompetent hamsters Mol Ther 3 431 437 10.1006/mthe.2001.0303 1:CAS:528:DC%2BD38XhvFKisro%3D 11319903 (Pubitemid 32509836)
5. DF Stojdl B Lichty S Knowles, et al. 2000 Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus Nat Med 6 821 825 10.1038/77558 1:CAS:528:DC%2BD3cXltVClsbk%3D 10888934 (Pubitemid 30469434)
6. DC Yu Y Chen M Seng J Dilley DR Henderson 1999 The addition of adenovirus type 5 region E3 enables calydon virus 787 to eliminate distant prostate tumor xenografts Cancer Res 59 4200 4203 1:CAS:528:DyaK1MXlvVSnu70%3D 10485454
7. C Herold-Mende J Karcher G Dyckhoff V Schirrmacher 2005 Antitumor immunization of head and neck squamous cell carcinoma patients with a virus-modified autologous tumor cell vaccine Adv Otorhinolaryngol 62 173 183 15608427 (Pubitemid 40014315)
8. A Phuangsab RM Lorence KW Reichard ME Peeples RJ Walter 2001 Newcastle disease virus therapy of human tumor xenografts: antitumor effects of local or systemic administration Cancer Lett 172 27 36 10.1016/S0304-3835(01)00617-6 1:CAS:528:DC%2BD3MXms12ltb8%3D 11595126 (Pubitemid 32823469)
9. Fu F, Liu C-y, Rui G, Yang B-f, Song C, Li X (2008) Anti-tumor effects of NDV D90 against tumor cells of A549 in vitro. Chin J Prevent Vet Med 30:179-182, 189
10. JM Donahue JT Mullen KK Tanabe 2002 Viral oncolysis Surg Oncol Clin N Am 11 661 680 10.1016/S1055-3207(02)00025-X 12487061 (Pubitemid 35205076)
11. J Zeng P Fournier V Schirrmacher 2002 Induction of interferon-alpha and tumor necrosis factor-related apoptosis-inducing ligand in human blood mononuclear cells by hemagglutinin-neuraminidase but not F protein of Newcastle disease virus Virology 297 19 30 10.1006/viro.2002.1413 1:CAS:528: DC%2BD38Xksl2nt74%3D 12083832 (Pubitemid 34734906)
12. JG Sinkovics CD Howe 1969 Superinfection of tumors with viruses Experientia 25 733 734 10.1007/BF01897593 1:STN:280:DyaF1M3mtVymsw%3D%3D 4308338
13. H Bian P Fournier R Moormann B Peeters V Schirrmacher 2005 Selective gene transfer in vitro to tumor cells via recombinant Newcastle disease virus Cancer Gene Ther 12 295 303 10.1038/sj.cgt.7700774 1:CAS:528:DC%2BD2MXhtlahsLw%3D 15605075 (Pubitemid 40315189)
14. M Janke B Peeters O de Leeuw, et al. 2007 Recombinant Newcastle disease virus (NDV) with inserted gene coding for GM-CSF as a new vector for cancer immunogene therapy Gene Ther 14 1639 1649 10.1038/sj.gt.3303026 1:CAS:528:DC%2BD2sXhtlalsLzI 17914407 (Pubitemid 350143189)
15. D Zamarin L Martinez-Sobrido K Kelly, et al. 2009 Enhancement of oncolytic properties of recombinant newcastle disease virus through antagonism of cellular innate immune responses Mol Ther 17 697 706 10.1038/mt.2008.286 1:CAS:528:DC%2BD1MXhs1Cksb0%3D 19209145
16. T Tong H Fan Y Tan, et al. 2006 C3d enhanced DNA vaccination induced humoral immune response to glycoprotein C of pseudorabies virus Biochem Biophys Res Commun 347 845 851 10.1016/j.bbrc.2006.05.091 1:CAS:528:DC%2BD28Xns1GktbY%3D 16857165 (Pubitemid 44118196)
17. M Grzelinski F Steinberg T Martens F Czubayko K Lamszus A Aigner 2009 Enhanced antitumorigenic effects in glioblastoma on double targeting of pleiotrophin and its receptor ALK Neoplasia 11 145 156 1:CAS:528: DC%2BD1MXhvVOls7g%3D 19177199
18. L Wei J Dai S Sun 2000 Construction of Newcastle disease virus hemagglutinin-neuraminidase (HN) gene and its antitumor immune response effects Acad J Second Military Med Univ 21 6
19. S Hegde JY Niederkorn 2000 The role of cytotoxic T lymphocytes in corneal allograft rejection Invest Ophthalmol Visual Sci 41 3341 3347 1:STN:280:DC%2BD3cvot1yiuw%3D%3D
20. GE Holt ML Disis 2008 Immune modulation as a therapeutic strategy for non-small-cell lung cancer Clin Lung Cancer 9 Suppl 1 S13 S19 10.3816/CLC.2008.s.003 1:CAS:528:DC%2BD1cXjsVCgu7s%3D 18540530 (Pubitemid 351345723)
21. WA Cassel RE Garrett 1965 Newcastle disease virus as an antineoplastic agent Cancer 18 863 868 10.1002/1097-0142(196507)18:7<863::AID- CNCR2820180714>3.0.CO;2-V 1:STN:280:DyaF2M7ht1yltg%3D%3D 14308233
22. V Schirrmacher C Haas R Bonifer C Ertel 1997 Virus potentiation of tumor vaccine T-cell stimulatory capacity requires cell surface binding but not infection Clin Cancer Res 3 1135 1148 1:STN:280:DyaK1M7htFSnsA%3D%3D 9815793
23. H Fan S Xiao T Tong, et al. 2008 Immunogenicity of porcine circovirus type 2 capsid protein targeting to different subcellular compartments Mol Immunol 45 653 660 10.1016/j.molimm.2007.07.009 1:CAS:528:DC%2BD2sXhtFalsLnL 17709139 (Pubitemid 47498590)
24. JS Cho JV Hsu SL Morrison 2009 Localized expression of GITR-L in the tumor microenvironment promotes CD8+ T cell dependent anti-tumor immunity Cancer Immunol Immunother 58 1057 1069 10.1007/s00262-008-0622-2 1:CAS:528: DC%2BD1MXltFSqsbs%3D 19018533
25. EN Klyushnenkova DV Kouiavskaia CA Berard RB Alexander 2009 Cutting edge: permissive MHC class II allele changes the pattern of antitumor immune response resulting in failure of tumor rejection J Immunol 182 1242 1246 1:CAS:528:DC%2BD1MXnsVemtA%3D%3D 19155468
26. L Zitvogel JI Mayordomo T Tjandrawan, et al. 1996 Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines J Exp Med 183 87 97 10.1084/jem.183.1.87 1:CAS:528:DyaK28XjsVChtA%3D%3D 8551248 (Pubitemid 26028748)
27. Z Qin G Richter T Schuler S Ibe X Cao T Blankenstein 1998 B cells inhibit induction of T cell-dependent tumor immunity Nat Med 4 627 630 10.1038/nm0598-627 1:CAS:528:DyaK1cXjtFKgtrY%3D 9585241 (Pubitemid 28237366)
28. JP Ridge F Di Rosa P Matzinger 1998 A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell Nature 393 474 478 10.1038/30989 1:CAS:528:DyaK1cXjs1Kms7s%3D 9624003 (Pubitemid 28292194)
29. SP Schoenberger RE Toes EI van der Voort R Offringa CJ Melief 1998 T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions Nature 393 480 483 10.1038/31002 1:CAS:528:DyaK1cXjs1Kmtbw%3D 9624005 (Pubitemid 28292196)
30. CS Umeshappa H Huang Y Xie, et al. 2009 CD4+ Th-APC with acquired peptide/MHC class I and II complexes stimulate type 1 helper CD4+ and central memory CD8+ T cell responses J Immunol 182 193 206 1:CAS:528:DC%2BD1cXhsFCis7nE 19109150